454 related articles for article (PubMed ID: 29408747)
21. Reproducibility of grading systems for endometrial endometrioid carcinoma and their relation with pathologic prognostic parameters.
Kapucuoglu N; Bulbul D; Tulunay G; Temel MA
Int J Gynecol Cancer; 2008; 18(4):790-6. PubMed ID: 17892460
[TBL] [Abstract][Full Text] [Related]
22. Tumor-infiltrating dendritic cells may be used as clinicopathologic prognostic factors in endometrial carcinoma.
Lijun Z; Xin Z; Danhua S; Xiaoping L; Jianliu W; Huilan W; Lihui W
Int J Gynecol Cancer; 2012 Jun; 22(5):836-41. PubMed ID: 22617481
[TBL] [Abstract][Full Text] [Related]
23. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis.
Vargas R; Rauh-Hain JA; Clemmer J; Clark RM; Goodman A; Growdon WB; Schorge JO; Del Carmen MG; Horowitz NS; Boruta DM
Gynecol Oncol; 2014 May; 133(2):216-20. PubMed ID: 24548726
[TBL] [Abstract][Full Text] [Related]
24. [Endometrial carcinoma: An histopathological and histoprognotic study about 62 patients in a center in the Tunisian north].
Doghri R; Yahyaoui Y; Gabsi A; Driss M; Boujelbene N; Charfi L; Amel M; Mrad K
Ann Pathol; 2018 Apr; 38(2):85-91. PubMed ID: 29398146
[TBL] [Abstract][Full Text] [Related]
25. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
26. The association of the microcystic, elongated and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasis.
Dogan Altunpulluk M; Kir G; Topal CS; Cetiner H; Gocmen A
J Obstet Gynaecol; 2015 May; 35(4):397-402. PubMed ID: 25279582
[TBL] [Abstract][Full Text] [Related]
27. A preoperative prediction model for predicting coexisting adnexa malignancy of patients with G1/G2 endometrioid endometrial cancer.
Shen L; Xie L; Li R; Shan B; Liang S; Tian W; Wang H; Ren Y
Gynecol Oncol; 2020 Nov; 159(2):402-408. PubMed ID: 32847677
[TBL] [Abstract][Full Text] [Related]
28. Coexisting ovarian malignancy in young women with endometrial cancer.
Walsh C; Holschneider C; Hoang Y; Tieu K; Karlan B; Cass I
Obstet Gynecol; 2005 Oct; 106(4):693-9. PubMed ID: 16199623
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer.
Scott SA; van der Zanden C; Cai E; McGahan CE; Kwon JS
Gynecol Oncol; 2017 May; 145(2):262-268. PubMed ID: 28359690
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers.
Sozen H; Vatansever D; Iyibozkurt AC; Topuz S; Ozsurmeli M; Salihoglu Y; Guzelbey B; Berkman S
J Obstet Gynaecol Res; 2015 Nov; 41(11):1813-9. PubMed ID: 26369625
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study.
Lee TS; Lee JY; Kim JW; Oh S; Seong SJ; Lee JM; Kim TJ; Cho CH; Kim SM; Park CY
Gynecol Oncol; 2013 Nov; 131(2):289-93. PubMed ID: 23994534
[TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of Twist1 and MMP-2 in endometrial endometrioid adenocarcinoma].
Wang XJ; Chen XH
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):588-91. PubMed ID: 23158991
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic analysis of the prognostic factors in women with coexistence of endometrioid adenocarcinoma in the endometrium and ovary.
Nishimura N; Hachisuga T; Yokoyama M; Iwasaka T; Kawarabayashi T
J Obstet Gynaecol Res; 2005 Apr; 31(2):120-6. PubMed ID: 15771637
[TBL] [Abstract][Full Text] [Related]
34. Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.
Barlin JN; Soslow RA; Lutz M; Zhou QC; St Clair CM; Leitao MM; Iasonos A; Hensley ML; Barakat RR; Matias-Guiu X; Abu-Rustum NR
Int J Gynecol Cancer; 2013 Nov; 23(9):1620-8. PubMed ID: 24126219
[TBL] [Abstract][Full Text] [Related]
35. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
[TBL] [Abstract][Full Text] [Related]
36. Ovarian conservation for young women with early-stage, low-grade endometrial cancer: a 2-step schema.
Matsuo K; Mandelbaum RS; Matsuzaki S; Klar M; Roman LD; Wright JD
Am J Obstet Gynecol; 2021 Jun; 224(6):574-584. PubMed ID: 33412129
[TBL] [Abstract][Full Text] [Related]
37. Coexisting ovarian malignancy in patients with clinical stage I endometrial carcinoma.
Akbayır O; Kuru O; Goksedef P; Numanoglu C; Corbacıoglu A; Cetin A
Arch Gynecol Obstet; 2012 Nov; 286(5):1241-5. PubMed ID: 22688443
[TBL] [Abstract][Full Text] [Related]
38. Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study.
Grandi G; Perrone AM; Chiossi G; Friso S; Toss A; Sammarini M; Facchinetti F; Botticelli L; Palma F; De Iaco P
Gynecol Oncol; 2019 Jul; 154(1):163-168. PubMed ID: 31104904
[TBL] [Abstract][Full Text] [Related]
39. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
Soliman PT; Slomovitz BM; Broaddus RR; Sun CC; Oh JC; Eifel PJ; Gershenson DM; Lu KH
Gynecol Oncol; 2004 Aug; 94(2):456-62. PubMed ID: 15297188
[TBL] [Abstract][Full Text] [Related]
40. Transvaginal/transrectal ultrasound for preoperative identification of high-risk cases in well- or moderately differentiated endometrioid carcinoma.
Alcázar JL; Pineda L; Caparrós M; Utrilla-Layna J; Juez L; Mínguez JA; Jurado M
Ultrasound Obstet Gynecol; 2016 Mar; 47(3):374-9. PubMed ID: 26033568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
